PHARMAKON A/S: Financial statements 2017
CVR: 10038839
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PHARMAKON A/S (CVR 10038839) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 114,963,000 and a net result of DKK 4,033,000 compared with DKK 3,471,000 the year before. That is an increase of 2.8% compared with the year before. The profit margin was 3.5%. Equity in the 2017 report amounted to DKK 75,824,000. The solvency ratio was 64.7%.
- Revenue
- DKK 114,963,000
- Gross Profit
- DKK 81,140,000
- Profit/Loss
- DKK 4,033,000
- Equity
- DKK 75,824,000
- Total Assets
- DKK 117,154,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 115 mio. | 81.1 mio. | 4 mio. | 75.8 mio. | - |
| 2016 | 111.8 mio. | 79.5 mio. | 3.5 mio. | 71.8 mio. | - |
| 2015 | 108.7 mio. | 76.3 mio. | 4.1 mio. | 68.3 mio. | - |
| 2014 | 111 mio. | - | 4 mio. | 64.2 mio. | 116 |
| 2013 | 105.8 mio. | - | 3 mio. | 60.3 mio. | 114 |
Official annual report
Keep an eye on PHARMAKON A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
PHARMAKON A/S has published its annual report for 2016. Revenue came to DKK 111,850,000, and the net result was DKK 3,471,000.
About PHARMAKON A/S
PHARMAKON A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1986. The company is registered under the industry Drift af hoteller og lignende overnatningsfaciliteter. The company was previously named DANMARKS APOTEKERFORENINGS KURSUSEJENDOM A/S. The management consists of Lotte Fonnesbæk. The board consists of Lars Pram Olsen (chair), Anja Claudia Hoffmann, Ditte Poulsen and Jeanette Hovgaard Rasmussen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 132 employees (2026). In 2025, the company reported revenue of DKK 143,466,000 and a net result of DKK -3,206,000 compared with DKK 1,890,000 the year before. Equity in the 2025 report amounted to DKK 98,649,000.